期刊文献+

中药提取物声敏剂在声动力治疗动脉粥样硬化中的应用 被引量:4

Application of sonosensitizers derived from Chinese herb products in sonodynamic therapy for atherosclerosis treatment
下载PDF
导出
摘要 目前,动脉粥样硬化引起的心血管疾病发生率越来越高,除昂贵的介入和搭桥治疗术外,寻求一种简单、有效且经济的治疗方法至关重要.声动力治疗是一种无创、安全的治疗方式,其在动脉粥样硬化治疗中的应用很有前景.声动力治疗中使用的药物为声敏剂,是影响其疗效的主要因素之一.研究人员一直致力于探讨不同种类声敏剂所带来的声动力效果在动脉粥样硬化治疗中起到的不同作用.近年来,在声敏剂的筛选研究中发现,中药提取物有很大的潜在声敏剂价值.简要总结了目前对声动力治疗机制及大黄素、姜黄素及其衍生物和金丝桃素作为声敏剂在声动力治疗动脉粥样硬化中的相关进展. At present, morbidity of cardiovascular disease induced by atherosclerosis (AS) is becoming higher. Besides expensive intervention and bypass surgery, it is extremely urgent to look for a popular and effective method for the treatment of AS. Sonodynamic therapy (SDT) is a non-invasive targeting therapy, and is promising for AS treatment based on the SDT-related research. Sonosensitizer, an application of SDT, is an entry points of the SDT investigation. Therefore, different sonodynamic effects with different sonosensitizers are investigated by researchers in AS treatment. In recent years, it is found that sonosensitizers derived from Chinese herb products play an important role in SDT, exerting potent sonodynamic effects for AS treatment. This review briefly summarizes the action of SDT and relevant development of SDT with emodin, curcumin, hypericin and its derived derivatives as sonosensitizers for AS treatment.
出处 《上海大学学报(自然科学版)》 CAS CSCD 北大核心 2016年第3期318-325,共8页 Journal of Shanghai University:Natural Science Edition
基金 国家自然科学基金资助项目(81571833 81271734 81000688) 地方高校国家级大学生创新创业训练计划资助项目(201510226011)
关键词 声动力治疗 声敏剂 中药提取物 动脉粥样硬化 sonodynamic therapy sonosensitizer Chinese herb product atherosclerosis
  • 相关文献

参考文献54

  • 1Lotta L A. Genome-wide association studies in atherothrombosis [J]. European Journal of Internal Medicine, 2010, 21(2): 74-78.
  • 2Mozaffarian D, Benjamin E J, Go A S, et al. Heart disease and stroke statistics—2012 update: a report from the American Heart Association [J]. Circulation, 2014, 131(4): e29-e322.
  • 3Ferguson J J, Kereiakes D J, Adgey A A, et al. Safe use of platelet GP Ⅱb/Ⅲa inhibitors [J]. American Heart Journal, 1998, 135(4): D40-D51.
  • 4Neuvonen P J, Mikko N, Backman J T. Drug interactions with lipid-lowering drugs: mechanisms and clinical relevance [J]. Clinical Pharmacology and Therapeutics, 2007, 80(6): 565-581.
  • 5Rockson S G, Lorenz D P, Cheong W F, et al. Photoangioplasty an emerging clinical cardiovascular role for photodynamic therapy [J]. Circulation, 2000, 102(5): 591-596.
  • 6Chen H, Zhou X, Yu G, et al. Recent progress in development of new sonosensitizers for sonodynamic cancer therapy [J]. Drug Discovery Today, 2014, 19(4): 502-509.
  • 7Sgolastra F, Petrucci A, Gatto R, et al. Photodynamic therapy in the treatment of chronic periodontitis: a systematic review and Meta-analysis [J]. Lasers in Medical Science, 2013, 28(2): 669-682.
  • 8Maria K, Konstantinos T, Archontoula M, et al. Vulnerable plaque and inflammation: potential clinical strategies [J]. Curr Pharm Des, 2011, 17(37): 4190-4209.
  • 9Martijn T, Paul B, Schellens J H M, et al. Photodynamic therapy in oncology [J]. Oncologist, 2006, 11(9): 1034-1044.
  • 10Yumita N, Nishigaki R, Umemura K, et al. Hematoporphyrin as a sensitizer of cell-damaging effect of ultrasound [J]. Jpn J Cancer Res, 1989, 80(3): 219-222.

同被引文献48

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部